Top Markets
#1 Purr Purr +60.74%
#2 Smilek to the Bank Smilek to the Bank +50.56%
#3 Pons Pons +26.51%
#4 Kinetiq Kinetiq +21.53%
#5 ApeX ApeX +21.13%
#6 Zora Zora +19.09%
#7 Not in Employment, Education, or Training Not in Employment, Education, or Training +19.05%
#8 Fake World Assets Fake World Assets +18.48%
#9 Non-Playable Coin Non-Playable Coin +18.16%
#10 OriginTrail OriginTrail +17.45%
Coin of the day
Purr Purr
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Daiichi Sankyo Company, Limited Daiichi Sankyo Company, Limited

Daiichi Sankyo Company, Limited

4568
Peringkat dalam Saham #758
Daiichi Sankyo Company, Limited is a global pharmaceutical enterprise actively... Daiichi Sankyo Company, Limited is a global pharmaceutical enterprise actively involved in the research, development, manufacturing, importation, marketing, and distribution of a diverse array of medicinal products worldwide. Its extensive product lineup addresses numerous therapeutic areas. In oncology, key offerings include trastuzumab deruxtecan, an anti-HER2 antibody drug conjugate, alongside treatments like Gefitinib for malignant tumors, Bicalutamide for prostate cancer, and Tamoxifen, an anti-breast cancer agent. For pain management, the company provides mirogabalin and loxoprofen (an anti-inflammatory analgesic). Diabetes treatments feature teneligliptin/canagliflozin and teneligliptin, with colesevelam serving dual purposes for hypercholesterolemia and type 2 diabetes. Other notable prescription drugs include lacosamide (an anti-epileptic), prasugrel (an antiplatelet), denosumab (for osteoporosis and bone disorders), edoxaban (an anticoagulant), esomeprazole (for ulcer treatment), memantine (for Alzheimer's disease), and laninamivir (for influenza). The company also supplies olmesartan (an antihypertensive), levofloxacin (an antibacterial), pravastatin (for hypercholesterolemia), Silodosin (for dysuria), and ferric carboxymaltose/iron sucrose injections for anemia. Beyond prescription medications, Daiichi Sankyo markets popular consumer health brands such as Lulu (a combination cold remedy), Loxonin S (an antipyretic/anti-inflammatory painkiller), Transino (for melasma and skin improvement), Minon (skincare), and the oral care lines Breath Labo and Clean Dental. The company further contributes to public health with various vaccines, including adsorbed cell culture-derived influenza, influenza HA, measles-rubella combined, and mumps vaccines. Its operations also extend beyond human pharmaceuticals to include veterinary drugs, cosmetics, medical equipment, food products, drinking water, and the production of active pharmaceutical ingredients (APIs) and intermediates. Daiichi Sankyo is collaborating with Guardant Health on the development of Guardant360 CDx, a companion diagnostic for Enhertu, specifically for advanced metastatic non-small cell lung cancer. Founded in 1899, the company is headquartered in Tokyo, Japan.
Harga Saham
$18.49
Terakhir disinkronkan: 2026-08-21
Kapitalisasi Pasar
$33.64B
Perubahan (1 hari)
-1.19%
Perubahan (1 tahun)
-25.90%
Negara
JP
Perdagangan Daiichi Sankyo Company, Limited (4568)

Kategori

Healthcare
Riwayat harga saham Daiichi Sankyo Company, Limited (4568)
Harga penutupan tertinggi: $17.11 pada 2026-08-01

Harga penutupan terendah: $8.83 pada 2008-06-01
Riwayat harga saham Daiichi Sankyo Company, Limited dari 2008 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) -10.21%
2025 -22.27%
2024 4.12%
2023 -13.87%
2022 27.52%
2021 -25.50%
2020 53.15%
2019 83.42%
2018 44.49%
2017 16.03%
2016 2.66%
2015 44.62%
2014 -20.53%
2013 17.61%
2012 -17.38%
2011 -13.59%
2010 6.33%
2009 -4.32%
2008 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $1.26K 76.64%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $270.77 51.02%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $265.40 26.02%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $493.69 44.66%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $152.42 74.45%
US